跳至主要内容
临床试验/ISRCTN59234325
ISRCTN59234325已完成未知

Elucidation of the effects of growth hormone (GH) deficiency and GH replacement on vascular risk and clot dynamics

eeds Teaching Hospitals NHS Trust (UK)0 个研究点目标入组 140 人开始时间: 2013年1月29日最近更新:

试验速览

阶段
未知
状态
已完成
发起方
入组人数
140

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

性别
All

入选标准

  • 1. Able to give written consent
  • 2. Adults over age 18 years, and of either gender with confirmed GHD (insulin stimulation test <3 ug/L)
  • 3. Other hormone replacement therapy stable for at least three months

排除标准

  • 1. Active malignancy
  • 2. An acute vascular event within three months of the study
  • 3. Any therapy other than hormone replacement
  • 4. Serum creatinine >120 mol/l
  • 5. Abnormal liver function tests (LFTs) [alanine transaminase (ALT) >3 fold upper limit of normal]

研究者

发起方
eeds Teaching Hospitals NHS Trust (UK)

相似试验

Growth hormone deficiency and clotting | 临床试验